Wednesday, June 23, 2021 8:48:13 AM
The Company entered into a patent license agreement on October 16, 2009 at a cost of $87,500
with Los Alamos National Laboratory to market Triggered Optical Biosensor and Integrated
Optical Biosensor System technology, developed at Los Alamos National Laboratory. The
Company is amortizing the cost of this license over a 20 year useful life and will review for
amortization an annual basis.
30-Jun-13 31-Dec-12
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
